Krensavage Asset Management, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001609251 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 15, 2022

Total Value: $288M (100.0% shares, 0.0% debt)

Holdings (10)

UTHR UNITED THERAPEUTICS CORP 15.3%

Value $44.26M Shares 204,812 Est. Cost $121.76 Unrealized +61.2%

REGN REGENERON PHARMACEUTICALS 15.1%

Value $43.63M Shares 69,080 Est. Cost $342.96 Unrealized +78.3%

ENTA ENANTA PHARMACEUTICALS INC 14.6%

Value $42.18M Shares 564,102 Est. Cost $44.67 Unrealized +75.7%

MCK MCKESSON CORP 13.5%

Value $38.88M Shares 156,424 Est. Cost $138.18 Unrealized +55.4%

ALKS ALKERMES PLC 11.6%

Value $33.56M Shares 1,442,965 Est. Cost $18.73 Unrealized +40.3%

EXEL EXELIXIS INC 9.9%

Value $28.46M Shares 1,557,119 Est. Cost $18.77 Unrealized +1.9%

— TARO PHARMACEUTICAL INDUS 9.4%

Value $27.01M Shares 538,967 Est. Cost $78.11 Unrealized —

BIIB BIOGEN INC 8.6%

Value $24.72M Shares 103,053 Est. Cost $311.97 Unrealized -17.6%

EGRX EAGLE PHARMACEUTICALS INC 1.9%

Value $5.422M Shares 106,487 Est. Cost $43.99 Unrealized +17.8%

— NEXTCURE INC 0.1%

Value $186K Shares 31,027 Est. Cost $9.95 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
UTHR	UNITED THERAPEUTICS CORP	204,812	$44.26M	15.3%	$121.76	+61.2%	COM	91307C102
REGN	REGENERON PHARMACEUTICALS	69,080	$43.63M	15.1%	$342.96	+78.3%	COM	75886F107
ENTA	ENANTA PHARMACEUTICALS INC	564,102	$42.18M	14.6%	$44.67	+75.7%	COM	29251M106
MCK	MCKESSON CORP	156,424	$38.88M	13.5%	$138.18	+55.4%	COM	58155Q103
ALKS	ALKERMES PLC	1,442,965	$33.56M	11.6%	$18.73	+40.3%	COM	G01767105
EXEL	EXELIXIS INC	1,557,119	$28.46M	9.9%	$18.77	+1.9%	COM	30161Q104
—	TARO PHARMACEUTICAL INDUS	538,967	$27.01M	9.4%	$78.11	—	COM	M8737E108
BIIB	BIOGEN INC	103,053	$24.72M	8.6%	$311.97	-17.6%	COM	09062X103
EGRX	EAGLE PHARMACEUTICALS INC	106,487	$5.422M	1.9%	$43.99	+17.8%	COM	269796108
—	NEXTCURE INC	31,027	$186K	0.1%	$9.95	—	COM	65343E108